Ad
RXDX - Prometheus Biosciences Stock Trading
Prometheus Biosciences Inc. Company Name:
RXDX Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
- The event will feature Prometheus management and key opinion leader presentations on PR600 target unveiling, scientific rationale, and corresponding therapeutic candidate, PRA052 - - PRA052 is a novel, first-in-class monoclonal antibody addressing a target with one of the stro...
-
- G lobal Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a roadmap for future studies - - Enrollment initiated in Cohort 2 of CDx+ patients to evaluate the company’s companion diagnostic - - Both APOLLO-CD an...
-
- Enrollment completed ahead of schedule for APOLLO-CD Phase 2a study of PRA023 in Crohn’s disease patients - - ARTEMIS-UC Phase 2 Cohort 1 enrollment on track with completion expected 3Q 2022 - - Both APOLLO-CD and ARTEMIS-UC topline results expected 4Q 2022 ȁ...
Ad
Important Investor News Alert (OTCMKTS: GTCH)
-
This second 3D, MP microchip Application Seeks to Further Strengthen GBT’s Multi-Dimensional Integrated Circuits Design and Manufacturing Concept SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT” or the ...